Home Politics Religion Media Biz Society Tech Travel Books Intl. Autos Automobiles
                        Aviation   Pharma   About Us   Feedback   Links
BUSINESS - BIRTH CONTROL PILLS AND WOMEN

Women clueless about makeup of birth control pills

New Survey Reveals Women are More Aware of the Ingredients in Their Food and Clothing Than the Ingredients of Their Birth Control Pills

 

MONTVILLE, N.J., June 1, 2005 /PRNewswire/ -- A new US survey reveals women pay much more attention to what's inside their food and clothing than what's inside their birth control pills. The survey was conducted in February 2005 by International Communications Research (ICR) of 400 women between the ages of 18 - 35 who are currently using, or have ever used, birth control pills. As many as 74 percent of women know what's inside their food and 60 percent know what's inside their clothing, but only 15 percent of women know what's inside their birth control pills.

The need for women to gain a better understanding of what's inside birth control pills is underscored by the fact that 65 percent of the women surveyed have switched two or more times between different types of birth control pills, with just over one-third switching because of side effects. Of the women who switched birth control pills, more than 71 percent are satisfied with their switch. This clearly indicates that while all pills may be equally effective, women can have different experiences with different pills. 

This also means that more than one-quarter of these women are still searching for the right pill.

"The adage 'it's what's inside that counts' can and should be applied to birth control pills," said Gloria Bachmann, M.D., Associate Dean for Women's Health, Professor of Obstetrics and Gynecology, and Professor of Medicine at the University of Medicine and Dentistry of New Jersey (UMDNJ-Robert Wood Johnson Medical School). "There are differences between birth control pills based on the types and amounts of hormones they contain. One example of this is the progestin drospirenone, which has unique properties." 

Since there are more than 40 brands of birth control pills to choose from today, it's important for women to learn about their birth control pills' ingredients, and what the differences may mean.

Education about birth control options had a positive impact on the life of Erin Callahan, a 31-year-old medical student in New York City. "I tried different birth control pills, but never found the one that was quite right for me," said Erin. "I was feeling frustrated, so I talked to my doctor about the differences between birth control pills. My physician recommended Yasmin(R), so I decided to try it. It's made a big difference for me."

Yasmin contains drospirenone, which has unique antiandrogenic and antimineralocorticoid properties.

"It's possible that drospirenone made the difference for Erin," noted Dr. Bachmann. "My advice to women about birth control pills is talk to your doctor about what he or she prescribes. Together, you can determine which one is best suited for you."

Other interesting findings from the survey include:

* Seventy-three percent of women polled admit they have purchased one food item over another based on its ingredients and 60 percent have bought an item of clothing based on its materials.

* Although 82 percent admit to not knowing what's inside their birth control pills, 74 percent believe there are differences between birth control pills and 71 percent agree that certain ingredients may have certain advantages for them.

* More than three-fourths of women believe the specific type of progestin in their birth control pills is important, but only two percent know that drospirenone is a form of progestin.

"It is very important to take a pill consistently every day to be effective," said Marie Foegh, M.D., DSc, Vice President, Medical Affairs FHC at Berlex Laboratories. "At the time when a woman switches birth control pills, she may discontinue one brand before filling the new prescription. Left unprotected for even one day, she is vulnerable to an unintended
pregnancy." An estimated 20 percent of the 3.5 million annual unintended pregnancies in the U.S. are due to pill discontinuation and compliance difficulties, according to the Alan Guttmacher Institute.
 

Pharma News Headlines

Cancer News

Cardiac News

US FDA News

Pharma industry news

LATEST UPDATES

Roche, Novartis lead on novel cancer therapies

US FDA grants fast track status for GSK’s HIV drug

Stem Cell Bill could be delayed in US

FDA warning on abortion drug Mifeprex (Mifepristone)

US FDA recalls Baxter’s intravenous pumps

US FDA grants tentative nod to Ranbaxy’s glimepiride

Lupin launches generic ceftriaxone in US

Hormonal contraceptives safe for long-term use: WHO

Abortion pill to carry 'black box' warning

Vaccines not linked to autism, say experts

Novartis acquires Bristol-Myers’ OTC business in US

Guidant alerts on flaw in pacemakers

Awareness on Medicare drug benefit scheme low in US

NIH review finds govt scientists having ties with pharma firms

US FDA to decide on Plan B morning-after pill by Sept 1

Painkiller patch Duragesic under US FDA probe over patients deaths

Legionnaire's disease outbreak in US hospital in New Rochelle 

Genepharm in pact with 3 Australian distributors 

UK has new generics reimbursement scheme 

Teva gets US FDA nod for mirtazapine anti-depressant 

US patent office rejects Pfizer’s Lipitor claims 

Aethlon Medical to start trials on HIV device in India 

Panel to decide fate of Advair, Serevent and Foradil asthma drugs 

Prohibitive costs mar cancer therapy 

FDA directs Palladone withdrawal

Blindness alert on impotence drugs  

Novartis files for breast cancer drug in US, Europe  

Merck readies for $10 billion Vioxx battle  

Speak up on menopause, campaign urges US women 

Direct-To-Consumer ads mislead patients: US Senator  

EU to decide on sops for developing kids drugs  

Zidovudine by Ranbaxy gets US FDA tentative nod

Parkinson's Disease therapy triggers gambling in some patients

Parkinson's Disease symptoms may be relieved by Azilect

Are obesity and diabetes just accelerated aging?

Reducing lung infection and inflammation due to Cystic Fibrosis

Viruses may help cure cancer by killing cancer cells

New product relieves tooth pain resulting from dental sensitivity 

Cervical Cancer detector may improve on Pap Smears

Dietary supplement capsule by Liqing banned in US

Cold Stone Creamery cake batter ice-creams recalled

Guidant defibrillator recall: US FDA makes three classifications

AIDS drug stavudine by Aurobindo Pharma gets tentative US FDA approval for PEPFAR

Gates Foundation donates for a good cause

Paxil CR resupply in US pharmacies announced by GlaxoSmithKline

Viagra users not at risk of blindness: Pfizer

Stem cell research gets boost from Li Ka-shing

BiDil heart failure drug for black patients approved

Restless leg syndrome could be messing up your sleep

Glaxo Smithkline in pact with IAVI to develop AIDS drug

Pfizer acquires Vicuron Pharma for $1.9 billion

German Remedies launches Fludara Oral

Ranbaxy acquires generic product portfolio from Efarmes

Sandoz files seven ANDAs of drugs going off-patent

Elder Pharma plans unit, brand acquisition

Novasite Pharma buys PsyCheNomicS

Chemokine gets US patent for novel cancer drug

Roche gets USFDA approval for oral Xeloda

Nectar Lifesciences plans Rs 90 crore IPO 

Glaxo inks co-promotion pact with Eisai for Paritec

Early Intervention required to Prevent Diabetes

AIDS drug ahoy!

Novartis launches AMD patient counselling programme

Nanobac Life Sciences, UCSF to study kidney stones 

Surface Logix commences phase I trial for PDE-5 inhibitor

Temasek sets up $112 million pharma JV

Contraceptive from Neem, courtesy DRDO  

US FDA to source anti-HIV drugs from Indian firms  

Chemists boycott Glaxo, Novartis products  

Maharashtra phases out nerve tissue-based rabies vaccine  

Last long, really long - new sex drug soon  

Johnson and Johnson demonstrates coronary stent safety

Novartis has better breast cancer treatment

Pfizer's investigational drug reduces tumor growth

New labeling for beta-blocker Coreg 

Glaxo applies for FDA approval for Flaurix

Investigational drug for Acute Bipolar Mania And Schizophrenia

Preclinical Data Support Link Between IL-9 and Airway Hyperresponsiveness Associated With Asthma

 

 

Home Politics Religion Media Biz Society Tech Travel Books Intl. Autos Automobiles
                        Aviation   Pharma   About Us   Feedback   Links

Latest updates    Contact Us - Feedback    About Us